Home / Companies / News / Novartis confirms 2020 outlook; sales, profit up amid Covid-19 outbreak

Novartis confirms 2020 outlook; sales, profit up amid Covid-19 outbreak

Core net income rises to $3.55 billion from $2.8 billion in 2019, against the average analyst forecast in a Refinitiv poll of $3.17 billion

Novartis India MD Milan Paleja to step down with effect from May 31

Premium

Sales rose to $12.3 billion from $11.1 billion in the year-ago period, above the poll average of $12 billion.

1 min read Last Updated : Apr 28 2020 | 8:03 PM IST

Swiss drugmaker Novartis boosted its first-quarter sales and profit and confirmed its 2020 targets as its generics units' sales were lifted during the coronavirus epidemic without disruptions in business for its main products.

The company's core net income rose to $3.55 billion, from $2.8 billion in 2019, against the average analyst forecast in a Refinitiv poll of $3.17 billion. Sales rose to $12.3 billion from $11.1 billion in the year-ago period, above the poll average of $12 billion.

Net income rose 16 per cent to $2.2 billion, from $1.9 billion last year. The Basel-based company still expects revenue to grow

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in